Skip to main content
T

Themison

Themison is a patient-centric platform that utilizes real-time engagement analytics and a mobile app to enhance communication and support throughout clinical trials. By simplifying complex medical information and personalizing patient experiences, the platform aims to reduce dropout rates and accelerate trial completion.

Copenhagen, DenmarkFounded 20238100+ followers
Updated 20 months ago

Funding

$165.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Clinical trials often suffer from high patient dropout rates due to complex medical information, communication challenges, and logistical difficulties, leading to delays and increased costs. Patients may struggle to understand trial requirements, adhere to treatment plans, and maintain consistent engagement throughout the study.

Solution

Themison offers a patient-centric platform designed to improve engagement and support throughout clinical trials, aiming to reduce dropout rates and accelerate trial completion. The platform leverages real-time engagement analytics to provide trial managers with insights into patient behavior, enabling proactive intervention and personalized support. A mobile app serves as a digital companion for patients, offering intelligent scheduling, clear journey maps, notifications, and direct communication channels. By simplifying complex information and personalizing the patient experience, Themison seeks to improve adherence and overall trial outcomes.

Target Audience

The primary customers are pharmaceutical companies, contract research organizations (CROs), and clinical trial sites seeking to improve patient engagement, reduce dropout rates, and accelerate clinical trial completion.

Features

  • Real-time engagement analytics dashboard for trial managers to monitor patient behavior and identify potential dropouts
  • Personalized patient workspaces with tailored educational content and engagement tools
  • Mobile app with intelligent scheduling, journey maps, notifications, and reminders
  • Chat functionality within the app for direct communication and support
  • Behavioral algorithm that refines trial designs, optimizes recruitment strategies, and improves treatment adherence
  • Targeted integrations with payment solutions and specialized apps to meet diverse demographic needs
This profile is AI-generated and may contain inaccuracies.